Emerging Technologies in Biotechnology: Therapeutic Modalities and Drug Development

Harvard Extension School

BIOT E-206

Section 1

CRN 17567

Begin Registration
This course examines the scientific, technological, and commercial foundations underlying emerging therapeutic modalities that are transforming modern biotechnology. Students explore major classes of therapeutics, including protein biologics, cell and gene therapies, and RNA-based medicines through a unified framework encompassing mechanism of action, molecular design, delivery systems, clinical translation, and real-world constraints. Using case-based learning, the course traces how innovative technologies emerge from academia or industry, progress through development, and ultimately reach patients. Emphasis is placed on understanding how delivery, manufacturability, and scalability determine the success or failure of therapeutic platforms. Students analyze real-world biotechnology companies, compare therapeutic modalities, and develop the ability to critically assess emerging technologies. By the end of the course, students apply a structured framework to evaluate and design novel therapeutic approaches grounded in scientific feasibility and unmet medical need.

Instructor Info

Rami Chakroun, PhD

Senior Engineer II, Team Lead II, Lipid Nanoparticle Process Development, Moderna


Meeting Info

M 7:40pm - 9:40pm (8/31 - 12/19)

Participation Option: Online Synchronous

Deadlines

Last day to register:

Prerequisites

Background in introductory biology and chemistry.

Notes

This course meets via web conference. Students must attend and participate at the scheduled meeting time. See minimum technology requirements.

All Sections of this Course

CRN Section # Participation Option(s) Instructor Section Status Meets Term Dates
17567 1 Online Synchronous Rami Chakroun Open M 7:40pm - 9:40pm
Aug 30 to Dec 18